palladium Pd 103

Known as: Pd 103, Palladium Pd-103, Palladium-103 
A radioactive form of palladium (a metallic element that resembles platinum). When used to treat prostate cancer, radioactive seeds (small pellets… (More)

Topic mentions per year

Topic mentions per year

1957-2018
02419572017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
PURPOSE To describe 18 years of experience with palladium-103 ((103)Pd) ophthalmic plaque brachytherapy. DESIGN Retrospective… (More)
Is this relevant?
2004
2004
OBJECTIVE To describe clinical experience with palladium 103 ((103)Pd) ophthalmic plaque radiotherapy for choroidal hemangioma… (More)
Is this relevant?
2003
2003
AIM To report 7 year results of ophthalmic plaque radiotherapy for exudative macular degeneration. METHODS In a phase I… (More)
  • table 1
Is this relevant?
2002
2002
PURPOSE To describe 11 years of experience with 103Pd ophthalmic plaque brachytherapy for intraocular melanoma. METHODS AND… (More)
Is this relevant?
2000
2000
PURPOSE A report of biochemical outcomes for patients treated with palladium-103 (Pd-103) brachytherapy over a fixed time… (More)
Is this relevant?
1999
1999
PURPOSE To evaluate ophthalmic plaque radiotherapy for the treatment of subretinal neovascularization associated with age-related… (More)
Is this relevant?
1998
1998
OBJECTIVE To evaluate the use of 3-dimensional (3D) ultrasonography for the localization of episcleral eye plaques during the… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
1997
1997
In recent years, there has been a resurgence of interest in interstitial radiation as a cost-effective and efficient method of… (More)
Is this relevant?
1993
1993
PURPOSE A dosimetry study comparing the use of I-125 vs. Pd-103 radioactive seeds for ophthalmic plaque brachytherapy. METHODS… (More)
Is this relevant?
1991
1991
We compared the ocular radiation distribution of palladium 103 (103Pd) vs iodine 125 (125I) ophthalmic plaques sewn to 12 human… (More)
Is this relevant?